ASP Isotopes Inc.

ASP Isotopes Inc. is an advanced materials company specializing in the development, production, and commercialization of isotopes for use across diverse sectors. Its core activities focus on enriching stable and radioactive isotopes through proprietary technologies such as the Aerodynamic Separation Process and Quantum Enrichment, targeting applications in nuclear medicine, medical diagnostics, pharmaceutical and agrochemical industries, as well as the semiconductor and energy markets. ASP Isotopes Inc. operates primarily from its facilities in Pretoria, South Africa, where a majority of its workforce and operational assets are based. The company’s product offerings include highly enriched isotopes like Molybdenum-100, Silicon-28, and Ytterbium-176—crucial for nuclear medical imaging, cancer diagnostics, and advanced electronics manufacturing. Additionally, ASP Isotopes is active in nuclear fuels development, including high-assay low-enriched uranium and lithium isotopes, aiming to address the growing needs of the next-generation nuclear energy industry. By leveraging modular, efficient, and environmentally conscious enrichment processes, the company plays a vital role in advancing healthcare, green energy, and quantum technology applications globally.